| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Vascular Biology, The Scripps Research Institute, La Jolla, California
Activated protein C (APC) acts as an anticoagulant by inhibiting coagulation factors Va and VIIIa. Although the liver appears to be the primary site of protein C (PC) synthesis, the demonstration that other components of this system are produced extrahepatically raises the possibility that PC itself is synthesized in other tissues. We therefore used quantitative reverse transcription-polymerase chain reaction, in situ hybridization, and immunohistochemistry to screen various murine tissues for PC expression. Relatively high levels of PC mRNA were detected in the kidney (35% of liver) and testis (22% of liver). PC mRNA and antigen were demonstrated in tubular epithelial cells in the renal cortex, in spermatogenic cells in the testis, and in epithelial cells in the epididymis. Low but significant levels of PC mRNA were detected in the epididymis (1.7% of the level in liver), brain (1.1% of liver), and lung (0.8% of liver). PC antigen was demonstrated in bronchial epithelial cells in the lung, in pyramidal neurons in the cerebrum, and in Purkinje cells in the cerebellum. The extrahepatic expression of PC mRNA (ie, in the kidney) was significantly decreased in mice with renal disease (eg, in MRL lpr/lpr mice with autoimmune lupus nephritis, in db/db mice with diabetic nephropathy, and in endotoxin-treated mice with acute renal injury). The decreased renal expression of PC may contribute to the increased procoagulant potential of the kidney during septic and inflammatory processes and to the progression of kidney disease associated with these conditions.
This article has been cited by other articles:
 |
|
 |
|
  M. J Schultz, B. Dixon, and M. Levi The pulmonary protein C system: preventive or therapeutic target in acute lung injury? Thorax, February 1, 2009; 64(2): 95 - 97. [Full Text] [PDF]
|
|
|
|
|
|
M. J Schultz and M. Levi Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury Thorax, July 1, 2007; 62(7): 563 - 564. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Odet, A. Verot, and B. Le Magueresse-Battistoni The Mouse Testis Is the Source of Various Serine Proteases and Serine Proteinase Inhibitors (SERPINs): Serine Proteases and SERPINs Identified in Leydig Cells Are under Gonadotropin Regulation Endocrinology, September 1, 2006; 147(9): 4374 - 4383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Odet, R. Guyot, P. Leduque, and B. Le Magueresse-Battistoni Evidence for Similar Expression of Protein C Inhibitor and the Urokinase-Type Plasminogen Activator System during Mouse Testis Development Endocrinology, March 1, 2004; 145(3): 1481 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sato, T. Miwa, H. Akatsu, N. Matsukawa, K. Obata, N. Okada, W. Campbell, and H. Okada Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not J. Immunol., July 15, 2000; 165(2): 1053 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Gingrich, C. E. Junge, P. Lyuboslavsky, and S. F. Traynelis Potentiation of NMDA Receptor Function by the Serine Protease Thrombin J. Neurosci., June 15, 2000; 20(12): 4582 - 4595. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
